Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dobucor
2. Dobuject
3. Dobutamin Fresenius
4. Dobutamin Hexal
5. Dobutamin Ratiopharm
6. Dobutamin Solvay
7. Dobutamin-ratiopharm
8. Dobutamina Inibsa
9. Dobutamina Rovi
10. Dobutamine
11. Dobutamine (+)-isomer
12. Dobutamine Hydrobromide
13. Dobutamine Lactobionate
14. Dobutamine Phosphate (1:1) Salt, (-)-isomer
15. Dobutamine Tartrate
16. Dobutamine Tartrate (1:1), (r-(r*,r*))-isomer
17. Dobutamine Tartrate (1:1), (s-(r*,r*))-isomer
18. Dobutamine, (-)-isomer
19. Dobutamine, Phosphate (1:1) Salt (+)-isomer
20. Dobutrex
21. Hydrobromide, Dobutamine
22. Hydrochloride, Dobutamine
23. Lactobionate, Dobutamine
24. Lilly 81929
25. Oxiken
26. Posiject
27. Tartrate, Dobutamine
1. 49745-95-1
2. Dobutamine Hcl
3. Dobutrex
4. Inotrex
5. Dobutamine (hydrochloride)
6. Dl-dobutamine Hydrochloride
7. 52663-81-7
8. Nsc-299583
9. Rac Dobutamine Hydrochloride
10. 0wr771djxv
11. 1,2-benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, Hydrochloride (1:1)
12. 49745-95-1 (hcl)
13. 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol Hydrochloride
14. 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride
15. (+-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol Hydrochloride
16. Chebi:4671
17. 4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol Hydrochloride
18. Smr000058435
19. Dobutamina Clorhidrato [spanish]
20. Sr-01000075265
21. Ly 81929
22. Einecs 256-464-1
23. Unii-0wr771djxv
24. Nsc 299583
25. Ly 46236
26. Posiject
27. 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, Hydrochloride
28. 1,2-benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, Hydrochloride
29. 4-(2-(4-(4-hydroxyphenyl)butan-2-ylamino)ethyl)benzene-1,2-diol Hydrochloride
30. 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol Hydrochloride
31. S-1000
32. Dobutrex (tn)
33. 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, Hydrochloride (1:1)
34. Prestwick_741
35. Mfcd00153795
36. 1,2-benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-
37. Dobutamine Hydrochloride In Dextrose 5%
38. Dobutamine Hydrochloride [usan:usp:ban:jan]
39. Schembl41609
40. 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, Hydrochloride, (+-)-
41. Mls000860012
42. Mls001332503
43. Mls001332504
44. Mls002222253
45. Regid_for_cid_65324
46. Chembl1200418
47. Dtxsid30964383
48. Dobutamine Hydrochloride, >=98%
49. Dobutamine Hydrochloride In Dextrose 5% In Plastic Container
50. Hms1569g05
51. Bcp13026
52. Tox21_500365
53. Dobutamine Hydrochloride [mi]
54. Nsc299583
55. Dobutamine Hydrochloride (jp17/usp)
56. Dobutamine Hydrochloride [jan]
57. Akos015907731
58. Ccg-220352
59. Ccg-221669
60. Dobutamine Hydrochloride [usan]
61. Ks-1050
62. Lp00365
63. (.+-.)-4-[2-[[3-(p-hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol Hydrochloride
64. 4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatecholhydrochloride
65. Dobutamine Hydrochloride [mart.]
66. Dobutamine Hydrochloride [who-dd]
67. Ncgc00093799-01
68. Ncgc00093799-02
69. Ncgc00261050-01
70. Ac-11653
71. Hy-15746
72. Ly-46236
73. Db-051684
74. D4335
75. Eu-0100365
76. Ft-0625557
77. Ft-0681170
78. Dobutamine Hydrochloride [ep Impurity]
79. Dobutamine Hydrochloride [orange Book]
80. D 0676
81. D00632
82. Dobutamine Hydrochloride [ep Monograph]
83. Dobutamine Hydrochloride [usp Impurity]
84. Dobutamine Hydrochloride [usp Monograph]
85. 368d042
86. A827836
87. Sr-01000075265-1
88. Sr-01000075265-3
89. Sr-01000075265-6
90. W-106009
91. Q27106435
92. Dobutamine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
93. Dobutamine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
94. 1, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, Hydrochloride, (.+-.)-
95. 3,4-dihydroxy-n-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenethylamine Hydrochloride
96. 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]aminoethyl-1,2-benzenediol Hydrochloride
97. Dobutamine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
98. ( Inverted Question Mark)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol Hydrochloride
99. (+/-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol Hydrochloride
100. 1,2-benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, Hydrochloride, (+/-)-
Molecular Weight | 337.8 g/mol |
---|---|
Molecular Formula | C18H24ClNO3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 337.1444713 g/mol |
Monoisotopic Mass | 337.1444713 g/mol |
Topological Polar Surface Area | 72.7 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 305 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Dobutamine hydrochloride |
Drug Label | Dobutamine Hydrochloride in 5% Dextrose Injection is a sterile, nonpyrogenic solution of Dobutamine Hydrochloride, USP and Dextrose, USP in Water for Injection, USP. Dobutamine hydrochloride is chemically designated as ()-4-[2-[[3-(p-hydroxyphenyl)... |
Active Ingredient | Dobutamine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 12.5mg base/ml |
Market Status | Prescription |
Company | Hospira; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Dobutamine hydrochloride |
Drug Label | Dobutamine Hydrochloride in 5% Dextrose Injection is a sterile, nonpyrogenic solution of Dobutamine Hydrochloride, USP and Dextrose, USP in Water for Injection, USP. Dobutamine hydrochloride is chemically designated as ()-4-[2-[[3-(p-hydroxyphenyl)... |
Active Ingredient | Dobutamine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 12.5mg base/ml |
Market Status | Prescription |
Company | Hospira; Eurohlth Intl |
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Adrenergic beta-1 Receptor Agonists
Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
11
PharmaCompass offers a list of Dobutamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dobutamine Hydrochloride manufacturer or Dobutamine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dobutamine Hydrochloride manufacturer or Dobutamine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Dobutamine Hydrochloride API Price utilized in the formulation of products. Dobutamine Hydrochloride API Price is not always fixed or binding as the Dobutamine Hydrochloride Price is obtained through a variety of data sources. The Dobutamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dobutamine hydrochloride in dextrose 5% in plastic container manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dobutamine hydrochloride in dextrose 5% in plastic container, including repackagers and relabelers. The FDA regulates Dobutamine hydrochloride in dextrose 5% in plastic container manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dobutamine hydrochloride in dextrose 5% in plastic container API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dobutamine hydrochloride in dextrose 5% in plastic container manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dobutamine hydrochloride in dextrose 5% in plastic container supplier is an individual or a company that provides Dobutamine hydrochloride in dextrose 5% in plastic container active pharmaceutical ingredient (API) or Dobutamine hydrochloride in dextrose 5% in plastic container finished formulations upon request. The Dobutamine hydrochloride in dextrose 5% in plastic container suppliers may include Dobutamine hydrochloride in dextrose 5% in plastic container API manufacturers, exporters, distributors and traders.
click here to find a list of Dobutamine hydrochloride in dextrose 5% in plastic container suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dobutamine hydrochloride in dextrose 5% in plastic container DMF (Drug Master File) is a document detailing the whole manufacturing process of Dobutamine hydrochloride in dextrose 5% in plastic container active pharmaceutical ingredient (API) in detail. Different forms of Dobutamine hydrochloride in dextrose 5% in plastic container DMFs exist exist since differing nations have different regulations, such as Dobutamine hydrochloride in dextrose 5% in plastic container USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dobutamine hydrochloride in dextrose 5% in plastic container DMF submitted to regulatory agencies in the US is known as a USDMF. Dobutamine hydrochloride in dextrose 5% in plastic container USDMF includes data on Dobutamine hydrochloride in dextrose 5% in plastic container's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dobutamine hydrochloride in dextrose 5% in plastic container USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dobutamine hydrochloride in dextrose 5% in plastic container suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dobutamine hydrochloride in dextrose 5% in plastic container Drug Master File in Japan (Dobutamine hydrochloride in dextrose 5% in plastic container JDMF) empowers Dobutamine hydrochloride in dextrose 5% in plastic container API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dobutamine hydrochloride in dextrose 5% in plastic container JDMF during the approval evaluation for pharmaceutical products. At the time of Dobutamine hydrochloride in dextrose 5% in plastic container JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dobutamine hydrochloride in dextrose 5% in plastic container suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dobutamine hydrochloride in dextrose 5% in plastic container Drug Master File in Korea (Dobutamine hydrochloride in dextrose 5% in plastic container KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dobutamine hydrochloride in dextrose 5% in plastic container. The MFDS reviews the Dobutamine hydrochloride in dextrose 5% in plastic container KDMF as part of the drug registration process and uses the information provided in the Dobutamine hydrochloride in dextrose 5% in plastic container KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dobutamine hydrochloride in dextrose 5% in plastic container KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dobutamine hydrochloride in dextrose 5% in plastic container API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dobutamine hydrochloride in dextrose 5% in plastic container suppliers with KDMF on PharmaCompass.
A Dobutamine hydrochloride in dextrose 5% in plastic container CEP of the European Pharmacopoeia monograph is often referred to as a Dobutamine hydrochloride in dextrose 5% in plastic container Certificate of Suitability (COS). The purpose of a Dobutamine hydrochloride in dextrose 5% in plastic container CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dobutamine hydrochloride in dextrose 5% in plastic container EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dobutamine hydrochloride in dextrose 5% in plastic container to their clients by showing that a Dobutamine hydrochloride in dextrose 5% in plastic container CEP has been issued for it. The manufacturer submits a Dobutamine hydrochloride in dextrose 5% in plastic container CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dobutamine hydrochloride in dextrose 5% in plastic container CEP holder for the record. Additionally, the data presented in the Dobutamine hydrochloride in dextrose 5% in plastic container CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dobutamine hydrochloride in dextrose 5% in plastic container DMF.
A Dobutamine hydrochloride in dextrose 5% in plastic container CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dobutamine hydrochloride in dextrose 5% in plastic container CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dobutamine hydrochloride in dextrose 5% in plastic container suppliers with CEP (COS) on PharmaCompass.
A Dobutamine hydrochloride in dextrose 5% in plastic container written confirmation (Dobutamine hydrochloride in dextrose 5% in plastic container WC) is an official document issued by a regulatory agency to a Dobutamine hydrochloride in dextrose 5% in plastic container manufacturer, verifying that the manufacturing facility of a Dobutamine hydrochloride in dextrose 5% in plastic container active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dobutamine hydrochloride in dextrose 5% in plastic container APIs or Dobutamine hydrochloride in dextrose 5% in plastic container finished pharmaceutical products to another nation, regulatory agencies frequently require a Dobutamine hydrochloride in dextrose 5% in plastic container WC (written confirmation) as part of the regulatory process.
click here to find a list of Dobutamine hydrochloride in dextrose 5% in plastic container suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dobutamine hydrochloride in dextrose 5% in plastic container as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dobutamine hydrochloride in dextrose 5% in plastic container API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dobutamine hydrochloride in dextrose 5% in plastic container as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dobutamine hydrochloride in dextrose 5% in plastic container and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dobutamine hydrochloride in dextrose 5% in plastic container NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dobutamine hydrochloride in dextrose 5% in plastic container suppliers with NDC on PharmaCompass.
Dobutamine hydrochloride in dextrose 5% in plastic container Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dobutamine hydrochloride in dextrose 5% in plastic container GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dobutamine hydrochloride in dextrose 5% in plastic container GMP manufacturer or Dobutamine hydrochloride in dextrose 5% in plastic container GMP API supplier for your needs.
A Dobutamine hydrochloride in dextrose 5% in plastic container CoA (Certificate of Analysis) is a formal document that attests to Dobutamine hydrochloride in dextrose 5% in plastic container's compliance with Dobutamine hydrochloride in dextrose 5% in plastic container specifications and serves as a tool for batch-level quality control.
Dobutamine hydrochloride in dextrose 5% in plastic container CoA mostly includes findings from lab analyses of a specific batch. For each Dobutamine hydrochloride in dextrose 5% in plastic container CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dobutamine hydrochloride in dextrose 5% in plastic container may be tested according to a variety of international standards, such as European Pharmacopoeia (Dobutamine hydrochloride in dextrose 5% in plastic container EP), Dobutamine hydrochloride in dextrose 5% in plastic container JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dobutamine hydrochloride in dextrose 5% in plastic container USP).